Reference : Standardization and validation of an agar gel immunodiffusion test for the diagnosis ...
Scientific journals : Article
Life sciences : Veterinary medicine & animal health
Standardization and validation of an agar gel immunodiffusion test for the diagnosis of equine infectious anemia using a recombinant p26 antigen.
Alvarez, I. [> >]
Gutierrez, G. [> >]
Vissani, A. [> >]
Rodriguez, Sabrina [National Institute of Agriculture Technology INTA-Castelar, Argentina > CNIA > Institute of Virology > >]
Barrandeguy, M. [> >]
Trono, K. [> >]
Veterinary Microbiology
Yes (verified by ORBi)
[en] Animals ; Base Sequence ; Equine Infectious Anemia/diagnosis/virology ; Immunodiffusion/methods/standards/veterinary ; Infectious Anemia Virus, Equine/genetics/immunology/isolation & purification ; Molecular Sequence Data ; RNA, Viral/chemistry/genetics ; Recombinant Proteins/chemistry/genetics/immunology ; Reproducibility of Results ; Reverse Transcriptase Polymerase Chain Reaction/veterinary ; Sensitivity and Specificity ; Viral Core Proteins/chemistry/genetics/immunology
[en] We developed and validated an agar gel immunodiffusion test (AGID) test for the diagnosis of equine infectious anemia (EIA) using as antigen the p26 protein of equine infectious anemia virus (EIAV) produced in the Escherichia coli expression system. The developed rp26-AGID test showed an excellent diagnostic relative sensitivity (100%) and specificity (100%) compared to a commercial AGID assay when 1855 field serum samples were analyzed. In addition, the rp26-AGID demonstrated to be a precise assay with excellent repeatability and reproducibility. In the analytical sensitivity trial, positive sera showed nearly the same endpoint dilutions for both compared tests. No positive-reactions were observed with 35 serum samples with antibodies related to other endemic agents and also with severely hemolysed samples, demonstrating that the rp26-AGID has an excellent analytical specificity. Complete concordance with blind previous results from five proficiency test panels confirmed the capability of the assay of accurate detection of EIAV antibodies. This is the first time that a recombinant AGID assay able to identify EIAV infections has been standardized and validated in Argentina according to international guidelines. Taking into account the results obtained, the p26-AGID could be adopted as an official test method for the diagnosis and control of EIA in this country.
Researchers ; Professionals

File(s) associated to this reference

Fulltext file(s):

Restricted access
1-s2.0-S0378113507000156-main.pdfPublisher postprint262.77 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.